Home › Aldermeesklierkanker › Massachusetts › Boston
Aldermeesklierkanker klinische studies in Boston, MA
43 studies voor Aldermeesklierkanker zoeken deelnemers op locaties in en rond Boston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RekruterenFase 1/2
- Research Site, Boston
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
RekruterenFase 1
- Dana-Farber Cancer Institute, Boston
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruterenFase 1
- Massachusetts General Hospital, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruterenFase 2
- Dana-Farber Cancer Institute - Oncology Department, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekruteren
- Dana-Farber Cancer Institute, Boston
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruterenFase 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekruterenFase 1
- PHN-012-001 Site, Boston
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RekruterenFase 3
- Dana Farber Cancer Institute, Boston
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekruterenFase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute (DFCI), Boston
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekruterenFase 3
- Investigative Site US022, Boston
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruterenFase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- Dana Farber Cancer Institute, Boston
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RekruterenObservatieonderzoek
- Dana-Farber Cancer Institute, Boston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruterenFase 1/2
- Massachusetts General Hospital - Main Campus, Boston
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekruterenFase 1
- Dana-Farber Cancer Institute, Boston
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekruterenFase 2
- Local Institution - 0124, Boston
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
RekruterenObservatieonderzoek
- Boston Children's Hospital, Boston
Resilience and Equity in Aging, Cancer, and Health (REACH)
Rekruteren
- Dana-Farber Cancer Institute, Boston
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekruterenFase 2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Pancreatic Cancer Early Detection Consortium
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Massachusetts General Hospital, Boston
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RekruterenFase 1
- Dana-Farber/Massachusetts General Hospital, Inc, Boston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruterenFase 1
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekruterenFase 1
- Research Site, Boston
- Research Site, Boston
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekruterenFase 1
- Dana Farber Cancer Institute, Boston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruterenFase 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
RekruterenVroege fase 1Gezonde vrijwilligers welkom
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Video Education With Result Dependent dIsclosure
Rekruteren
- Dana Farber Cancer Institute, Boston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- Dana Farber Cancer Institute, Boston
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Massachusetts General Hospital, Boston
A Study of MGC028 in Participants With Advanced Solid Tumors
RekruterenFase 1
- Mass General Brigham, Boston
- Dana Farber/Harvard Cancer Center, Boston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekruterenFase 1/2
- Massachusetts General Hospital, Boston
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
RekruterenFase 2
- Beth Israel Deaconess Medical Center - Division of Hematology/Oncology, Boston
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekruterenFase 1/2
- Dana-Farber Cancer Institute, Boston
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
RekruterenFase 2
- Massachusetts General Hospital, Boston
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
Rekruteren
- Dana Farber Cancer Institute, Boston
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruterenFase 2
- Ohio State University-Telemedicine, Boston
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
RekruterenFase 3
- Beth Israel Deaconess Medical Center, Boston
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
RekruterenFase 1/2
- Massachusetts General Hospital, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
Rekruteren
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekruterenFase 3
- Dana Farber Cancer Center, Harvard University, Boston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekruterenFase 1/2
- Dana Farber Cancer Institute, Boston
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
RekruterenObservatieonderzoek
- Beth Israel Deaconess Medical Center, Boston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekruterenFase 1
- Dana Farber/Partners Cancer Care Inc, Boston
Aldermeesklierkanker studies in andere steden
- Houston, TX61 studies
- New York City, NY60 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
- San Diego, CA24 studies
Andere studies in Boston
- Borstkanker112 studies
- Niet-kleincellige longkanker90 studies
- Kanker (alle vormen)85 studies
- Metastatische kanker63 studies
- Colorectale kanker63 studies
- Longkanker62 studies
- Eierstokkanker61 studies
- Prostaatkanker59 studies
- Depressie52 studies
- Endometriumkanker50 studies
- Hartfalen44 studies
- Acute myeloïde leukemie44 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.